Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals Statistics

Total Valuation

SYRS has a market cap or net worth of $65.15 million. The enterprise value is $67.10 million.

Market Cap	65.15M
Enterprise Value	67.10M

Important Dates

The last earnings date was Thursday, October 31, 2024, before market open.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

SYRS has 26.81 million shares outstanding. The number of shares has increased by 31.77% in one year.

Current Share Class	n/a
Shares Outstanding	26.81M
Shares Change (YoY)	+31.77%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	32.39%
Float	13.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	231.58
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	173.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25

Current Ratio	2.25
Quick Ratio	2.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.92

Financial Efficiency

Return on equity (ROE) is -776.96% and return on invested capital (ROIC) is -94.28%.

Return on Equity (ROE)	-776.96%
Return on Assets (ROA)	-59.88%
Return on Capital (ROIC)	-94.28%
Revenue Per Employee	$5,676
Profits Per Employee	-$1.44M
Employee Count	68
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.02% in the last 52 weeks. The beta is 1.59, so SYRS's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-2.02%
50-Day Moving Average	1.94
200-Day Moving Average	4.72
Relative Strength Index (RSI)	57.62
Average Volume (20 Days)	453,108

Short Selling Information

The latest short interest is 952,604, so 3.55% of the outstanding shares have been sold short.

Short Interest	952,604
Short Previous Month	999,929
Short % of Shares Out	3.55%
Short % of Float	6.84%
Short Ratio (days to cover)	4.74

Income Statement

In the last 12 months, SYRS had revenue of $386,000 and -$97.82 million in losses. Loss per share was -$2.66.

Revenue	386,000
Gross Profit	-88.25M
Operating Income	-111.52M
Pretax Income	-131.56M
Net Income	-97.82M
EBITDA	-110.18M
EBIT	-111.52M
Loss Per Share	-$2.66

Balance Sheet

The company has $58.28 million in cash and $60.23 million in debt, giving a net cash position of -$1.95 million or -$0.07 per share.

Cash & Cash Equivalents	58.28M
Total Debt	60.23M
Net Cash	-1.95M
Net Cash Per Share	-$0.07
Equity (Book Value)	-11.12M
Book Value Per Share	-0.41
Working Capital	35.54M

Cash Flow

In the last 12 months, operating cash flow was -$100.02 million and capital expenditures -$38,000, giving a free cash flow of -$100.05 million.

Operating Cash Flow	-100.02M
Capital Expenditures	-38,000
Free Cash Flow	-100.05M
FCF Per Share	-$3.73

Margins

Gross Margin	n/a
Operating Margin	-28,891.71%
Pretax Margin	-25,340.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,640.74%

Dividends & Yields

SYRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.77%
Shareholder Yield	-31.77%
Earnings Yield	-150.14%
FCF Yield	-153.58%

Analyst Forecast

The average price target for SYRS is $5.00, which is 105.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	105.76%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	122.94%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on September 19, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Sep 19, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

SYRS has an Altman Z-Score of -15.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.52
Piotroski F-Score	n/a